Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/NOVARTIS-AG-9364983/news/Novartis-Zulassungsantrag-fur-MS-Mittel-Ofatumumab-von-FDA-und-EMA-angenommen-30050710/?utm_source=whatsapp&utm_medium=social&utm_campaign=share